Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
SHL Aktienübersicht
Die Siemens Healthineers AG entwickelt, fertigt und vertreibt über ihre Tochtergesellschaften eine Reihe von diagnostischen und therapeutischen Produkten und Dienstleistungen für Gesundheitsdienstleister weltweit.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Siemens Healthineers AG Wettbewerber
Preisentwicklung & Leistung
| Historical stock prices | |
|---|---|
| Current Share Price | €53.38 |
| 52 Week High | €58.14 |
| 52 Week Low | €44.39 |
| Beta | 0.75 |
| 1 Month Change | 2.85% |
| 3 Month Change | -4.98% |
| 1 Year Change | -0.78% |
| 3 Year Change | 13.89% |
| 5 Year Change | 47.54% |
| Change since IPO | 76.76% |
Aktuelle Nachrichten und Updates
Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06
Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Recent updates
Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Aktionärsrenditen
| SHL | DE Medical Equipment | DE Markt | |
|---|---|---|---|
| 7D | -0.6% | -1.4% | -0.8% |
| 1Y | -0.8% | -3.9% | 3.2% |
Rendite im Vergleich zur Industrie: SHL übertraf die Branche German Medical Equipment, die im vergangenen Jahr eine Rendite von -3.2 erzielte.
Rendite vs. Markt: SHL hinter dem Markt German zurück, der im vergangenen Jahr eine Rendite von 8.6 erzielte.
Preisvolatilität
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.6% |
Stabiler Aktienkurs: SHL hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.
Volatilität im Zeitverlauf: SHLDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| n/a | 71,400 | Bernd Montag | www.siemens-healthineers.com |
Die Siemens Healthineers AG entwickelt, fertigt und vertreibt über ihre Tochtergesellschaften eine Reihe von diagnostischen und therapeutischen Produkten und Dienstleistungen für Gesundheitsdienstleister weltweit. Das Unternehmen ist in vier Segmenten tätig: Imaging, Diagnostics, Varian und Advanced Therapies. Das Segment Imaging bietet Magnetresonanztomographie, Computertomographie, Röntgensysteme, molekulare Bildgebung und Ultraschallsysteme an.
Siemens Healthineers AG's Grundlagenzusammenfassung
| SHL grundlegende Statistiken | |
|---|---|
| Marktanteil | €59.56b |
| Gewinn(TTM) | €1.84b |
| Umsatz(TTM) | €21.87b |
32.4x
Kurs-Gewinn-Verhältnis2.7x
Kurs-Umsatz-VerhältnisIst SHL zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| SHL Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | €21.87b |
| Kosten der Einnahmen | €13.67b |
| Bruttogewinn | €8.20b |
| Sonstige Ausgaben | €6.36b |
| Umsatz | €1.84b |
Zuletzt gemeldete Gewinne
Mar 31, 2024
Datum des nächsten Gewinnberichts
Jul 31, 2024
| Gewinn per Aktie (EPS) | 1.65 |
| Bruttomarge | 37.50% |
| Nettogewinnspanne | 8.41% |
| Schulden/Eigenkapital-Verhältnis | 76.4% |
Wie hat sich SHL auf lange Sicht entwickelt?
Historische Performance und Vergleiche